Skip to content
PubMed This is a summary of 42 peer-reviewed journal articles Updated
Clinical Immunology

Autosomal dominant combined immunodeficiency due to partial IL6ST deficiency: A Patient Guide

At a Glance

Autosomal dominant partial IL6ST deficiency is a rare inherited immune disorder that can cause repeated skin and lung infections, eczema, dental and joint changes, and a muted fever response during serious illness. Preventive treatment and regular lung monitoring help limit lasting damage.

Autosomal dominant (AD) partial IL6ST deficiency is an exceptionally rare genetic condition that belongs to a group of disorders known as Hyper-IgE syndromes (HIES). At its core, this diagnosis means that a specific signaling hub in your cells, called the GP130 receptor, is not working at full capacity [1]. Because this receptor acts like a universal adapter for many important immune and growth signals, its partial failure creates a unique pattern of health challenges that affect the skin, the immune system, and the skeletal system [1][2].

The biological consequence of this deficiency is a “muffled” immune response. Specifically, the body struggles to hear the messages sent by cytokines like IL-6 and IL-11, which are thought to contribute to triggering fevers and coordinating bone development [1][3]. This quiet signaling explains why you may experience recurrent skin abscesses and lung infections (pneumonia). Because your internal “alarm” is dampened, you might not always develop the high fevers or typical lab markers that usually signal a serious illness [1][4]. However, it is crucial to remember that a normal temperature or normal lab results do not rule out a serious infection.

Alongside these infections, some people deal with severe eczema and distinct physical features, such as baby teeth that do not fall out on their own (retained deciduous teeth) and extra-flexible joints [1][5].

One of the most striking features of this condition is how much it varies from person to person. Even within the same family, one individual might face significant health hurdles while another has only mild symptoms [1][6]. Because this is an autosomal dominant condition, a person with this diagnosis has a 50% chance of passing the genetic variant to each biological child, making genetic counseling an important part of family planning.

The primary long-term goal is the preservation of lung health. Over time, repeated infections can lead to structural changes such as bronchiectasis (scarred airways) or air-filled cysts called pneumatoceles, which can become homes for opportunistic molds like Aspergillus [7][8].

Living well with AD-IL6ST deficiency requires a shift toward a proactive, “prevention-first” mindset. Management relies on a dedicated, individualized care team and the closely monitored use of preventative (prophylactic) treatments to stop infections before they can cause lasting damage [9][10]. While the rarity of the diagnosis can feel overwhelming, understanding the specific nature of your immune system allows you and your doctors to stay ahead of the condition, ensuring that you receive the right support at the right time [11].

Common questions in this guide

What is autosomal dominant partial IL6ST deficiency?
It is a very rare inherited combined immunodeficiency caused by reduced function of the GP130 signaling receptor. The condition can affect infection defense, the skin, the lungs, teeth, joints, and bone development, and its severity can vary widely even within one family.
Can I have a serious infection without a high fever?
Yes. Weakened IL-6 and IL-11 signaling can make fever or usual inflammation signals less noticeable, so a normal temperature or normal lab results do not rule out a serious infection. New or worsening symptoms should be discussed promptly with the healthcare team.
What symptoms can partial IL6ST deficiency cause?
Possible features include repeated skin abscesses, pneumonia or other lung infections, severe eczema, retained baby teeth, and unusually flexible joints. Some people have mild symptoms, while others have more significant infections or complications.
How can this condition affect the lungs over time?
Repeated lung infections can damage the airways, causing bronchiectasis, or lead to air-filled spaces called pneumatoceles. These changes can allow opportunistic molds such as Aspergillus to grow, so protecting lung health is a major long-term goal.
What treatments can help prevent infections?
Management is individualized and may include closely monitored preventive antibiotics or antifungal medicines to reduce the risk of infection. Your healthcare team can decide which approach is appropriate based on your health and infection pattern.
What does this diagnosis mean for my future children?
Because the condition is autosomal dominant, a person with the genetic variant has a 50% chance of passing it to each biological child. Genetic counseling can explain testing options and help with family-planning decisions.

Get notified when new evidence is published on Autosomal dominant combined immunodeficiency due to partial IL6ST deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (11)
  1. 1

    Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome.

    Béziat V, Tavernier SJ, Chen YH, et al.

    The Journal of experimental medicine 2020; (217(6)) doi:10.1084/jem.20191804.

    PMID: 32207811
  2. 2

    A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis.

    Schwerd T, Twigg SRF, Aschenbrenner D, et al.

    The Journal of experimental medicine 2017; (214(9)):2547-2562 doi:10.1084/jem.20161810.

    PMID: 28747427
  3. 3

    Hyper-IgE syndrome, 2021 update.

    Minegishi Y

    Allergology international : official journal of the Japanese Society of Allergology 2021; (70(4)):407-414 doi:10.1016/j.alit.2021.07.007.

    PMID: 34419355
  4. 4

    Functional and structural analysis of cytokine-selective IL6ST defects that cause recessive hyper-IgE syndrome.

    Chen YH, Zastrow DB, Metcalfe RD, et al.

    The Journal of allergy and clinical immunology 2021; (148(2)):585-598 doi:10.1016/j.jaci.2021.02.044.

    PMID: 33771552
  5. 5

    The Human GP130 Cytokine Receptor and Its Expression-an Atlas and Functional Taxonomy of Genetic Variants.

    Chen YH, van Zon S, Adams A, et al.

    Journal of clinical immunology 2023; (44(1)):30 doi:10.1007/s10875-023-01603-7.

    PMID: 38133879
  6. 6

    New Dominant-Negative IL6ST Variants Expand the Immunological and Clinical Spectrum of GP130-Dependent Hyper-IgE Syndrome.

    Arlabosse T, Materna M, Riccio O, et al.

    Journal of clinical immunology 2023; (43(7)):1566-1580 doi:10.1007/s10875-023-01517-4.

    PMID: 37273120
  7. 7

    Interventional pulmonary procedures and their outcomes in patients with STAT3 hyper IgE syndrome.

    Mahdaviani SA, Ghadimi S, Fallahi M, et al.

    BMC surgery 2023; (23(1)):289 doi:10.1186/s12893-023-02193-2.

    PMID: 37741967
  8. 8

    Pulmonary features and stage of disease in adult patients with hyper-IgE syndrome: a single-centre clinical study and literature review.

    Xie T, Xu N, Zhao H, et al.

    Orphanet journal of rare diseases 2025; (20(1)):270 doi:10.1186/s13023-025-03749-6.

    PMID: 40462219
  9. 9

    Autosomal Dominant Hyper-IgE Syndrome in the USIDNET Registry.

    Gernez Y, Freeman AF, Holland SM, et al.

    The journal of allergy and clinical immunology. In practice 2018; (6(3)):996-1001 doi:10.1016/j.jaip.2017.06.041.

    PMID: 28939137
  10. 10

    Hemoptysis in a Patient with Elevated Immunoglobulin E.

    Gernez Y, Tsuang A, Smith TD, et al.

    The journal of allergy and clinical immunology. In practice 2016; (4(6)):1054-1058 doi:10.1016/j.jaip.2016.08.003.

    PMID: 27693026
  11. 11

    Clinical features, genetics, treatment, and long-term outcomes of STAT3 hyper-IgE syndrome: Single-center cohort analysis.

    Freeman AF, Wang C, Urban A, et al.

    The Journal of allergy and clinical immunology 2026; (158(2)):569-581 doi:10.1016/j.jaci.2026.04.012.

    PMID: 42061468

This page is for informational purposes only and does not constitute medical advice about IL6ST deficiency. Your healthcare team should tailor infection monitoring, preventive treatment, and genetic counseling to your situation.